A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

NCT06541847 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
25
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Healx Limited